// App-Quantinova.ai

e14088 : Phase I study of everolimus combined with metformin for patients with advanced cancer.

Researchers

Presenter

  • Remco Jurriaan Molenaar

Principal Investigators

  • Tim van de Venne

  • Mariette Weterman

  • Heinz-Josef Klumpen

  • Ron Mathot

  • Dirk Richel

  • Johanna Wilmink

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Dose Escalation

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved